维普中文期刊产品整合服务
74篇 您的检索式:作者名="Defor TE"
    题名 作者 年代 出处 被引量
1Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation 显示文摘MacMillan ML Radloff GA DeFor TE 2003Br J Haematol2003,121,4:1
2Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell don and HLA disparity on treatment-related mortality and survival 显示文摘Wagner JE Barker JN DeFor TE 2002Blood2002,100,5:1
3Effect of conditioning regimen intensity on acute myetoid leukemia outcomes after umbilical cord blood transplantation显示文摘Oran B Wagner JE DeFor TE 2011Biol Blood Marrow Transplant2011,17,9:1
4Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors显示文摘 DeFor TE McGlave PB 2001Am J Med2001,110,5:1
5Diffuse alveolar hemor- rhage and infection-associated alveolar hemorrhage fol- lowing hematopoietic stern cell transplantation: related and high-risk clinical syndromes显示文摘Majhail NS Parks K Defor TE 2006Biol Blood Marrow Transplant2006,12,10:1
6Allogeneie hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival显示文摘Kumar P Defor TE Brunstein C 2008Biol Blood Marrow Transplant2008,14,12:1
7Bronchiolitis obliterans in chronic graft-versus-host disease:analysis of risk factors and treatment out- comes显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Man ow Transplant2003,,:1
8Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival 显示文摘Wagner JE Barker JN DeFor TE 2002Blood2002,100,5:1
9Bronchiolitis obliterans in chronicgraft-versus-host disease : analysis of risk factors and treatment outcomes显示文摘Dudek AZ Mahaseth H Defor TE 2003Biol Blood Marrow Transplant2003,9,10:1
10Composite end point of graft-versus-host disease-free, relapse-free sur- vival after allogeneic hematopoietic cell transplantation显示文摘Holtan SG DeFor TE Aleksandr L 2015Blood2015,125,8:1
11Bronchiolitis obliter- ans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes 显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Marrow Transplant2003,9,10:1
12Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival显示文摘Wagner JE Barker JN Defor TE Baker KS Blazar BR Eide C 2002Blood2002,100,5:1
13Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors显示文摘Davies SM Defor TE Mcglave PB American Journal of Medicine0,,:1
14The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission显示文摘Lemer RE Thomas W Defor TE 2007Biol Blood Marrow Transplant2007,13,4:1
15The best endpoint for acute GVHD treatment trials显示文摘MacMillan ML DeFor TE Weisdorf DJ 0,,:1
16Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation 显示文摘Cardoso SM DeFor TE Tilley LA 2004Br J Haematol2004,126,5:1
17Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors显示文摘Davies SM DeFor TE McGlave PB 2001Am J Med2001,110,:1
18New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors显示文摘Baker KS DeFor TE Bums LJ 2003J Clin Oncol2003,21,7:1
19New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors显示文摘Baker KS DeFor TE Burns LJ 2003J Clin Oncol2003,21,7:1
20Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non- malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival 显示文摘Wagner JE Barker JN DeFor TE 2002Blood2002,100,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费